Contact Us
Home SC 13G/A

SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filing Details

Document Details

Form
SC 13G/A
Filing Date
Jan 5, 2023
Document Date
Jan 5, 2023
Form Description
An amendment to the SC 13G filing
Filing Group
Other
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC